Multiples has invested Rs 6,850 million, along with a few other marquee financial investors, for a ~9.3 per cent stake in BDR Pharma, a statement from Multiples notified.
The consortium of investors participating along with Multiples include institutional investors such as the investment arm of QRG Invest (Havells Family Office) and high networth individuals Nishant Agarwal, Avighna Group and Mallika Srinivasan from TAFE, the statement mentioned.
The funds will be used by the company to build additional research and development capabilities in current and emerging areas, accelerate investments in manufacturing capacity expansion and enhance the degree of vertical integration. The company will also selectively pursue inorganic opportunities to build scale, the statement added.